Zeying Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zeying Zhang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Meng Su
Key Laboratory of Green Printing, CAS Research/Education Center for Excellence in Molecular Sciences, Beijing Engineering Research Center of Nanomaterials for Green Printing Technology, Beijing National Laboratory for Molecular Sciences (BNLMS), Institute of Chemistry, Chinese Academy of Sciences (ICCAS), Beijing 100190, China
3 shared publications Baorui Guo
Senior Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
1 shared publicationCongwei Liu
Senior Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
1 shared publicationFan Yang
Senior Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
1 shared publication- Gang Cheng
Senior Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
1 shared publication - Jianning Zhang
Senior Department of Neurosurgery, Chinese PLA General Hospital, Beijing 100853, China
1 shared publication
Latest Publications
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (11) , 3555-3581
Multiplexed nanophotonic biosensing and deep learning-driven protein quantification for traumatic brain injury diagnosis at the point of care
Traumatic brain injury (TBI) triage and monitoring demand rapid, sensitive, and deployable biomarker assays. We present an AI-integrated nanophotonic biosensor enabling ultrasensitive multiplexed quantification of S100B, GFAP, and UCH-L1 across diverse human biofluids. The sensing substrate consists of polystyrene single chains formed via liquid-confinement self-assembly and functionalized with antibodies. Selenium nanoparticles are pre-incubated with specimens to form SeNP–antigen complexes that co-localize on the chains, generating high-contrast elastic scattering. A standardized four-zone layout employs hydrophilic/hydrophobic patterning to passively isolate reaction domains without physical barriers. A deep learning pipeline facilitates device-agnostic quantification from images captured using various microscopy systems, including professional setups and smartphone-based adaptations. Validation with 195 clinical specimens from 75 individuals (TBI patients and controls) spanning serum, urine, saliva, and cerebrospinal fluid demonstrated a detection limit of 1 pg mL−1 and strong agreement with ELISA (R2 > 0.93) for all biomarkers, with consistent performance across imaging modalities. The workflow is completed in ∼30 min and requires only a smartphone in portable modes, demonstrating a proof-of-concept for point-of-care neurotrauma diagnostics and highlighting a potential pathway toward AI-assisted decentralized TBI management.
- 11 May 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (11) , 3555-3581
Multiplexed nanophotonic biosensing and deep learning-driven protein quantification for traumatic brain injury diagnosis at the point of care
Traumatic brain injury (TBI) triage and monitoring demand rapid, sensitive, and deployable biomarker assays. We present an AI-integrated nanophotonic biosensor enabling ultrasensitive multiplexed quantification of S100B, GFAP, and UCH-L1 across diverse human biofluids. The sensing substrate consists of polystyrene single chains formed via liquid-confinement self-assembly and functionalized with antibodies. Selenium nanoparticles are pre-incubated with specimens to form SeNP–antigen complexes that co-localize on the chains, generating high-contrast elastic scattering. A standardized four-zone layout employs hydrophilic/hydrophobic patterning to passively isolate reaction domains without physical barriers. A deep learning pipeline facilitates device-agnostic quantification from images captured using various microscopy systems, including professional setups and smartphone-based adaptations. Validation with 195 clinical specimens from 75 individuals (TBI patients and controls) spanning serum, urine, saliva, and cerebrospinal fluid demonstrated a detection limit of 1 pg mL−1 and strong agreement with ELISA (R2 > 0.93) for all biomarkers, with consistent performance across imaging modalities. The workflow is completed in ∼30 min and requires only a smartphone in portable modes, demonstrating a proof-of-concept for point-of-care neurotrauma diagnostics and highlighting a potential pathway toward AI-assisted decentralized TBI management.
- Open Access
- 1 December 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (12) , 791
Rapid Detection of Staphylococcus aureus from Gym Environments for Health Risk Monitoring Using Printed Nanochains-Based Biosensors
Gyms are indoor environments in which many people perform physical exercise and could potentially increase the risks of bacterial contamination and dissemination. Staphylococcus aureus (S. aureus) is one of the most prevalent bacteria in community-acquired infections; thus, the rapid detection and continuous monitoring of S. aureus are crucial for evaluating the hygienic status of gym environments. This work describes the fabrication of a nanochain-based biosensor for S. aureus detection using carboxyl-modified polystyrene (PS) nanoparticles functionalized with a specific antibody. When target bacteria bind to the nanochains, they yield distinct color changes which support the directly visualizable analysis of optical images, recorded using optical microscopy or even a smart mobile phone. In addition to high portability, this biosensor is also capable of the quantification and continuous monitoring of the bacterial load in a gym environment over a broad linear range (100 CFU/mL~105 CFU/mL), with a detection limit of 1 CFU/mL. In summary, this study validated the applicability of the biosensors for the rapid detection and real-time monitoring of gym environmental pathogens.
- 1 December 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (12) , 791
Open AccessRapid Detection of Staphylococcus aureus from Gym Environments for Health Risk Monitoring Using Printed Nanochains-Based Biosensors
Gyms are indoor environments in which many people perform physical exercise and could potentially increase the risks of bacterial contamination and dissemination. Staphylococcus aureus (S. aureus) is one of the most prevalent bacteria in community-acquired infections; thus, the rapid detection and continuous monitoring of S. aureus are crucial for evaluating the hygienic status of gym environments. This work describes the fabrication of a nanochain-based biosensor for S. aureus detection using carboxyl-modified polystyrene (PS) nanoparticles functionalized with a specific antibody. When target bacteria bind to the nanochains, they yield distinct color changes which support the directly visualizable analysis of optical images, recorded using optical microscopy or even a smart mobile phone. In addition to high portability, this biosensor is also capable of the quantification and continuous monitoring of the bacterial load in a gym environment over a broad linear range (100 CFU/mL~105 CFU/mL), with a detection limit of 1 CFU/mL. In summary, this study validated the applicability of the biosensors for the rapid detection and real-time monitoring of gym environmental pathogens.
- Open Access
- 1 January 2024
- Published by Innovation Press Co., Limited in The Innovation Materials
- Vol. 2 (3) , 100076-1-100076-3
Colloidal self-assembly in biosensing strategies for biomarkers diagnosis
Rapid and high-throughput detection of biomarkers plays an important role in disease diagnosis, prognosis, and monitoring treatment. Existing diagnostic tools that rely on genetic testing and antibody recognition can provide the required sensitivity and specificity. However, these methods need multiple labeling steps for the signal amplification, which are tedious and time-consuming. To address these issues, self-assembled colloidal superstructures, especially for the nanophotonic structures, exhibit many optical sensing properties in response to external stimuli, which lays the foundation for developing the next-generation biosensors. Herein, we discuss the potential of self-assembled nanophotonic-based biosensors for achieving low-cost, high-sensitive, multiplexed detection of various biomarkers, including nucleic acids, proteins, and exosomes. We conclude the current challenges in optical colloidal biosensors and offer insights into their further advances towards the smart healthcare.
- 1 January 2024
- Published by Innovation Press Co., Limited in The Innovation Materials
- Vol. 2 (3) , 100076-1-100076-3
Open AccessColloidal self-assembly in biosensing strategies for biomarkers diagnosis
Rapid and high-throughput detection of biomarkers plays an important role in disease diagnosis, prognosis, and monitoring treatment. Existing diagnostic tools that rely on genetic testing and antibody recognition can provide the required sensitivity and specificity. However, these methods need multiple labeling steps for the signal amplification, which are tedious and time-consuming. To address these issues, self-assembled colloidal superstructures, especially for the nanophotonic structures, exhibit many optical sensing properties in response to external stimuli, which lays the foundation for developing the next-generation biosensors. Herein, we discuss the potential of self-assembled nanophotonic-based biosensors for achieving low-cost, high-sensitive, multiplexed detection of various biomarkers, including nucleic acids, proteins, and exosomes. We conclude the current challenges in optical colloidal biosensors and offer insights into their further advances towards the smart healthcare.